{
    "2018-04-26": [
        [
            {
                "time": "",
                "original_text": "[买入-A评级]智飞生物(300122)季报点评：业绩略超预期 多个重磅品种助推公司未来高成长",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "季报",
                        "业绩",
                        "超预期",
                        "重磅品种",
                        "高成长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]智飞生物(300122)季报点评：HPV疫苗和三联苗销售驱动公司业绩快速增长",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "HPV疫苗",
                        "三联苗",
                        "销售",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]智飞生物(300122)季报点评：预防微卡申报生产 一季度业绩高增长",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "预防微卡",
                        "申报生产",
                        "一季度",
                        "业绩高增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "生物疫苗龙头企业纷纷晒业绩 这些个股被券商“强推”",
                "features": {
                    "keywords": [
                        "生物疫苗",
                        "龙头企业",
                        "业绩",
                        "券商推荐"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "数据王：21只个股逆势创出历史新高 医药股占据一半",
                "features": {
                    "keywords": [
                        "数据王",
                        "个股",
                        "历史新高",
                        "医药股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：新产品相继上市助力后续发力 增持评级",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "新产品",
                        "上市",
                        "后续发力",
                        "增持评级"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}